On June 18th, the Chinese herbal medicine index stood at 2,737 points, unchanged from yesterday and reaching a new historical high in the cycle, up 180.72% from its lowest point of 975 points on November 25, 2019. (Note: The cycle refers to June 30th, 2019 to present)

According to the price monitoring of SunSirs, in the 24th week of 2023 (6.12-6.16), there were a total of 5 products that rose or fell in the price list of traditional Chinese medicine, 2 products that fell, and 1 product that rose or fell to 0. The main commodities that have increased include: Codonopsis pilosula (13.67%), Angelica (7.24%), and Astragalus (5.88%); The main commodities that fell were Sanchi (-6.36%) and Chinese Wolfberry (-1.18%). Last week's average increase or decrease was 3.47%.

According to the monitoring of the commodity market analysis system of the SunSirs, the incoming goods from the production area are not large, and the market inventory is relatively low. Currently, the market remains stable, with Hubei's unified price ranging from 125 to 130 RMB and Sichuan's unified price ranging from 140 to 145 RMB.

The origin and market of traditional Chinese medicine are still in an overheated state, and it is difficult to predict the price increase of varieties. Perhaps today is already high priced peony bark, Codonopsis pilosula, Atractylodes macrocephala, etc., perhaps it is suddenly emerging stiff silkworms, kudzu, morning glory, etc., perhaps tomorrow is the production exceeding sales of Chonglou, Chuanxiong, Cheqianzi. There are still many varieties with rising prices in the market, while the decline in price varieties is not significant, all of which fall within the normal fluctuation range of merchant shipments.

If you have any questions, please feel free to contact SunSirs with support@sunsirs.com.